Dr. Hye Jin Choi
Claim this profileYonsei University Health System - Severance Hospital
Area of expertise
Bile Duct Cancer
Hye Jin Choi has run 2 trials for Bile Duct Cancer. Some of their research focus areas include:
Pancreatic Adenocarcinoma
Hye Jin Choi has run 1 trial for Pancreatic Adenocarcinoma. Some of their research focus areas include:
Clinical Trials Hye Jin Choi is currently running
Tinengotinib
for Bile Duct Cancer
This trial is testing an oral medication called Tinengotinib for patients with a specific type of bile duct cancer that has not responded to other treatments. The medication works by blocking a protein that helps cancer cells grow. The goal is to see if Tinengotinib can slow down or stop the cancer in these patients.
Recruiting
2 awards
Phase 3
Nab-Paclitaxel + Gemcitabine +/- SBP-101
for Pancreatic Cancer
This trial is testing a new drug called SBP-101 combined with two existing cancer drugs, nab-paclitaxel and gemcitabine, in patients with advanced pancreatic cancer. The goal is to see if adding SBP-101 can help these patients live longer and improve their quality of life. SBP-101 might work by making cancer cells easier to kill with the other drugs.
Recruiting
2 awards
Phase 2 & 3
10 criteria
More about Hye Jin Choi
Clinical Trial Related
2 years of experience running clinical trials · Led 6 trials as a Principal Investigator · 3 Active Clinical Trials
Treatments Hye Jin Choi has experience with
- Gemcitabine
- Nab Paclitaxel
- NovoTTF-100L(P)
- NovoTTF-200T
- ZW25 (Zanidatamab)
- Futibatinib
Breakdown of trials Hye Jin Choi has run
Pancreatic Adenocarcinoma
Gallbladder Cancer
Biliary Tract Cancer
Cholangiocarcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Hye Jin Choi specialize in?
Hye Jin Choi focuses on Bile Duct Cancer and Pancreatic Adenocarcinoma. In particular, much of their work with Bile Duct Cancer has involved Stage IV patients, or patients who are FGFR2 positive.
Is Hye Jin Choi currently recruiting for clinical trials?
Yes, Hye Jin Choi is currently recruiting for 3 clinical trials in Seoul Seoul Teugbyeolsi. If you're interested in participating, you should apply.
Are there any treatments that Hye Jin Choi has studied deeply?
Yes, Hye Jin Choi has studied treatments such as Gemcitabine, nab paclitaxel, NovoTTF-100L(P).
What is the best way to schedule an appointment with Hye Jin Choi?
Apply for one of the trials that Hye Jin Choi is conducting.
What is the office address of Hye Jin Choi?
The office of Hye Jin Choi is located at: Severance Hospital Yonsei University Health System - PPDS, Seoul, Seoul Teugbyeolsi 03722 Korea, Republic of. This is the address for their practice at the Severance Hospital Yonsei University Health System - PPDS.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.